Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPOWERED: Oral Octreotide in Acromegaly
NCT02685709Phase 3Completed
- Sponsor
- Chiasma
- Start
- Feb 2016
- Primary completion
- Oct 2020
- Modality
- Peptides
- Countries
- 13
01
Overview
A Phase 3 trial of octreotide in acromegaly, sponsored by Chiasma. Started Feb 2016; status: completed.
02
Drugs
octreotide
03
Conditions
acromegaly
Beyond the preview
Go deeper on NCT02685709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02685709.